Sep 27, 2013: A bipartisan bill in Congress aimed at strengthening oversight of compounding pharmacies and preventing harm to patients would make drug compounders' participation in a new regulatory category voluntary rather than mandatory, a significant change from previous bills addressing the issue.

Outside link:
What the bill is likely to do is create a market where hospitals and clinics choose to buy drugs from registered compounders because they would be expected to have higher quality standards